Skip to main content
search
Press Coverage

How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?

Publication: Pharma's Almanac

Advances in personalized medicine are transforming patient care through tailored therapies and innovative technologies. In this article, Certara’s Dr. Fran Brown explains why biosimulation will become a key enabler of personalized medicine.

Published: January 31, 202

Learn more about Drug Development Services

Enhance and optimize your drug development process with decades of experience

Learn more

You May Also Like

How Model-informed drug development rescue projects from a risky situation​
How Model-informed drug development rescue projects from a risky situation​Case Study

How Model-informed drug development rescue projects from a risky situation​

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning
Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity PlanningPublication

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara
From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and CertaraWebinar

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara